Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 1Phase 2 Interventional

ASIS for Botox in Cervical Dystonia

ClinicalTrials.gov ID: NCT02074293

Public ClinicalTrials.gov record NCT02074293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02074293
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
li nguyen
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • Gadolinium Drug
  • Efficacy of Botox intramuscularly at Week 6 Drug
  • Efficacy of Botox intramuscularly at Week 12 Drug
  • Efficacy of Botox intramuscularly at Week 18 Drug
  • Efficacy of Botox intramuscularly at Week 24 Drug
  • Efficacy of Botox intramuscularly at Week 30 Drug
  • Efficacy of Botox subdermally at Week 6 Drug
  • Efficacy of Botox subdermally at Week 12 Drug
  • Efficacy of Botox subdermally at Week 18 Drug
  • Efficacy of Botox subdermally at Week 24 Drug
  • Efficacy of Botox subdermally at Week 30 Drug
  • Adverse Reactions of Botox intramuscularly Drug
  • Adverse Reactions of Botox subdermally Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2015
Primary completion
May 31, 2016
Completion
May 31, 2017
Last update posted
Jun 23, 2015

2016 – 2017

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Automatic Subdermal Injector System, Inc Westminster California 92683

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02074293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2015 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02074293 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →